Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1 Colorectal Neoplasms 1

Interventions

Oxaliplatin 20 Fluorouracil 20 Leucovorin 19 Bevacizumab 16 Cetuximab 13 Irinotecan 12 Capecitabine 8 regorafenib 5 Radiotherapy 5 Nivolumab 5 Drug Therapy 5 aflibercept 4 Radiosurgery 4 Neoadjuvant Therapy 4 Magnetic Resonance Spectroscopy 4 Chemotherapy, Adjuvant 4 Biopsy 4 pembrolizumab 3 durvalumab 3 atezolizumab 3 Specimen Handling 3 Folfox protocol 3 Cyclophosphamide 3 trifluridine tipiracil drug combination 2 tremelimumab 2 tislelizumab 2 poly(I).poly(c12,U) 2 futuximab 2 fludarabine 2 avelumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Colorectal Neoplasms × 5-aminolevulinic acid hexyl ester × Clear all

NCT03272659 2019-09-18

PDD

Sir Mortimer B. Davis - Jewish General Hospital

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡